Subscribe to RSS
DOI: 10.1055/a-2136-6941
Ökonomische Erhebung prämenstrueller Symptomatik – Deutsche Übersetzung der Kurzversion der Premenstrual Assessment Form und deren psychometrische Überprüfung
Efficient assessment of premenstrual symptoms – German translation of the shortened Premenstrual Assessment Form and its psychometric evaluation
Zusammenfassung
Prämenstruelle Symptomatik ist eine weitverbreitete und dennoch wenig beforschte Problematik. Im deutschen Sprachraum existiert bislang kein Instrument zur Erhebung des breiten Spektrums an möglichen Symptomen und deren Ausprägung. Aus diesem Grund wurden die Kurzversionen der Premenstrual Assessment Form mit 20 und 10 Items übersetzt und an einer Stichprobe von N=147 menstruierenden Personen validiert. Die internen Konsistenzen der 20er und 10er Item-Versionen sind hoch (Cronbachs αPAF20=0,93 und αPAF10=0,88) und vergleichbar mit den Originalversionen. Eine Faktorenanalyse identifizierte zwei Skalen, die psychologische und physiologische Symptomatik erfassen. Konvergente Validität wird durch den Zusammenhang mit dem PMS-Impact Questionnaire (rPAF20=0,66, p<.001) belegt. Dieser ist signifikant höher (z=2.67, p=0,004) als der Zusammenhang mit dem Brief Symptom Inventory-18 (rPAF20=0,50, p<.001), wodurch die divergente Validität als gegeben angenommen wird. Es wurden außerdem Cut-Off Werte für Verdachtsdiagnosen auf Basis der Diagnosekriterien des DSM-V für beide Kurzformen berechnet. Die übersetzte Premenstrual Assessment Form ist ein valides, reliables, ökonomisches und flexibel einsetzbares Instrument. Es eignet sich zur Quantifizierung prämenstrueller Symptomatik in der Forschung.
Abstract
Premenstrual symptomatology is a widespread and yet under-researched problem. To date, there is no German instrument for assessing the broad spectrum of possible symptoms and their degree of expression. For this reason, the short versions of the Premenstrual Assessment Form with 20 and 10 items were translated and validated in a sample of N=147 menstruating persons. The internal consistencies of the 20-item and 10-item versions are high (Cronbach's αPAF20=0.93 and αPAF10=0.88, respectively) and comparable to the original versions. Factor analysis identified two scales that assess psychological and physiological symptoms. Convergent validity was demonstrated by a correlation with the PMS Impact Questionnaire (rPAF20=0.66, p<.001). This association was significantly higher (z=2.67, p=0.004) than the correlation with the Brief Symptom Inventory-18 (rPAF20=0.50, p<0.001), which verifies divergent validity. Additionally, cut-off values for suspected diagnoses based on DSM-V diagnostic criteria for both short forms were calculated. The translated Premenstrual Assessment Form is a valid, reliable, and parsimonious instrument that can be used flexibly. It is suitable for quantifying premenstrual symptomatology in research.
Schlüsselwörter
Prämenstruelles Syndrom - Prämenstruelle dysphorische Störung - Fragebogen - Gütekriterien - MenstruationKey words
premenstrual syndrome - premenstrual dysphoric disorder - questionnaire - psychometric properties - menstruationPublication History
Received: 16 September 2022
Accepted: 15 February 2023
Article published online:
24 August 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Direkvand-Moghadam A, Sayehmiri K, Delpisheh A. et al. Epidemiology of Premenstrual Syndrome (PMS)-A Systematic Review and Meta-Analysis Study. J Clin Diagn Res 2014; 8: 106-109 DOI: 10.7860/JCDR/2014/8024.4021.
- 2 Tschudin S, Bertea PC, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch Womens Ment Health 2010; 13: 485-494 DOI: 10.1007/s00737-010-0165-3.
- 3 American Psychiatric Association. Hrsg. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013. DOI: 10.1176/appi.books.9780890425596
- 4 Hantsoo L, Epperson CN. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep 2015; 17: 87 DOI: 10.1007/s11920-015-0628-3.
- 5 MacKrill K, Groom KM, Petrie KJ. The effect of symptom-tracking apps on symptom reporting. Br J Health Psychol 2020; 25: 1074-1085 DOI: 10.1111/bjhp.12459.
- 6 Bentz D, Steiner M, Meinlschmidt G. SIPS--Screening-Instrument für prämenstruelle Symptome. Die deutsche Version des Premenstrual Symptoms Screening Tool zur Erfassung klinisch relevanter Beschwerden. Nervenarzt 2012; 83: 33-39 DOI: 10.1007/s00115-010-3210-6.
- 7 Kues JN, Janda C, Kleinstäuber M. et al. How to measure the impact of premenstrual symptoms? Development and validation of the German PMS-Impact Questionnaire. Women Health 2016; 56: 807-826 DOI: 10.1080/03630242.2015.1118734.
- 8 Bergant A, Schneider A, Tran T. et al. Diagnostik prämenstrueller Störungen – Deutschsprachige Fassung und Validierung der "Premenstrual Tension Syndrome Observer and Self-Rating Scale" (PMTS-O und -SR Scale) und der Visuellen Analogskala für prämenstruelle Störungen (VAS-PmS). Dtsch Med Wochenschr 2004; 129: 188-192 DOI: 10.1055/s-2004-817664.
- 9 Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symptoms. Journal of Psychosomatic Research 2002; 52: 223-237 DOI: 10.1016/S0022-3999(02)00297-0.
- 10 Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives. Gynecol Endocrinol 2004; 19: 320-334 DOI: 10.1080/0951590400018215.
- 11 Halbreich U, Endicott J, Schacht S. et al. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand 1982; 65: 46-65 DOI: 10.1111/j.1600-0447.1982.tb00820.x.
- 12 Allen SS, McBride CM, Pirie PL. The shortened premenstrual assessment form. The Journal of Reproductive Medicine 1991; 36: 769-772
- 13 Braverman PK. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Journal of Pediatric and Adolescent Gynecology 2007; 20: 3-12 DOI: 10.1016/j.jpag.2006.10.007.
- 14 Epstein J, Santo RM, Guillemin F. A review of guidelines for cross-cultural adaptation of questionnaires could not bring out a consensus. J Clin Epidemiol 2015; 68: 435-441 DOI: 10.1016/j.jclinepi.2014.11.021.
- 15 Terwee CB, Bot SDM, Boer MRde. et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42 DOI: 10.1016/j.jclinepi.2006.03.012.
- 16 Spitzer C, Hammer S, Löwe B. et al. Die Kurzform des Brief Symptom Inventory (BSI -18): erste Befunde zu den psychometrischen Kennwerten der deutschen Version. Fortschr Neurol Psychiatr 2011; 79: 517-523 DOI: 10.1055/s-0031-1281602.
- 17 Yonkers KA, McCunn KL. Comorbidity of premenstrual syndrome and premenstrual dysphoric disorder with other psychiatric conditions. In: Shaughn O'Brien PM, Rapkin A, Schmidt PJ, Hrsg. The premenstrual disorders: PMS and PMDD. Boca Raton: CRC Press; 2007: 49-54
- 18 Cortina JM. What is coefficient alpha? An examination of theory and applications. Journal of Applied Psychology 1993; 78: 98-104 DOI: 10.1037/0021-9010.78.1.98.
- 19 Câmara RdA, Köhler CA, Frey BN. et al. Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life. Braz J Psychiatry 2017; 39: 140-146 DOI: 10.1590/1516-4446-2016-1953.
- 20 Freeman EW, Rickels K, Schweizer E. et al. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med 1995; 25: 309-315 DOI: 10.1017/s0033291700036205.
- 21 Matsumoto T, Egawa M, Kimura T. et al. Comparison between retrospective premenstrual symptoms and prospective late-luteal symptoms among college students. Gynecological and Reproductive Endocrinology and Metabolism 2021; 01/2021: 31-41